Loading…
Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients
Hemodialysis (HD) patients are at increased risk of reactivation of latent tuberculosis infection (LTBI) compared with the general population. QuantiFERON-TB Gold (QFT-G) for LTBI detection is more promising than tuberculin skin test (TST) in HD patients. In our study, we evaluated the value of the...
Saved in:
Published in: | Annals of thoracic medicine 2016-04, Vol.11 (2), p.114-120 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73 |
---|---|
cites | cdi_FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73 |
container_end_page | 120 |
container_issue | 2 |
container_start_page | 114 |
container_title | Annals of thoracic medicine |
container_volume | 11 |
creator | Seyhan, Ekrem Cengiz Gunluoglu, Gulşah Gunluoglu, Mehmet Zeki Tural, Seda Sökücü, Sinem |
description | Hemodialysis (HD) patients are at increased risk of reactivation of latent tuberculosis infection (LTBI) compared with the general population. QuantiFERON-TB Gold (QFT-G) for LTBI detection is more promising than tuberculin skin test (TST) in HD patients.
In our study, we evaluated the value of the TST and QFT-G In-Tube (QFG-IT) test in the development of active tuberculosis (TB), in the HD patients, and in healthy controls.
The study enrolled 95 HD patients and ninety age-matched, healthy controls. The TST and QFG-IT were performed. All the subjects were followed up 5 years for active TB disease.
Compared to the healthy controls, a high prevalence of LTBI was found in the HD patients by QFG-IT (41% vs. 25%). However, no significant difference was detected by TST (32% vs. 31%). Four HD patients and one healthy control progressed to active TB disease within the 5-year follow-up. For active TB discovered subjects, QFG-IT was positive in all, but TST was positive in two (one patient and one healthy control). In HD patients; sensitivity, specificity, positive and negative predictive values of QFG-IT, and TST for active TB was 100% and 25%, 62% and 67%, 10%, and 3%, and 100% and 95%, respectively. Receiver operating curve analysis revealed that the results are significantly different (P = 0.04).
QFG-IT test is a more useful diagnostic method than TST for detecting those who will progress to active TB in HD patients. |
doi_str_mv | 10.4103/1817-1737.180023 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_efb0a7bd5b7e4407a25d7014063bae79</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_efb0a7bd5b7e4407a25d7014063bae79</doaj_id><sourcerecordid>1789035927</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoqVw54QiceklxY7t2L4goaotK1UU0N4tJ550vTjxYjsr9bfwZ3FIt2I5cfHH-J3HM6O3KN5idEExIh-wwLzCnPALLBCqybPiFEspKsIYf57Ph-eT4lWMW4RYQwl_WZzUHDdCMHla_PoawNgu2T2Ue-0mKH1fpg2UaWohdJOzYxl_5CVBTKUeTflt0mOy11ff775UB5GPNpY33plyNVbrHFzkvQ-lgT04vxtgTDNaL18dJWb6BgZvrHYP832nk83y-Lp40WsX4c3jflasr6_Wl5-r27ub1eWn26pjNUkVEaKXCIsa91IQbnpSY2M4IxiZhjQIjGBaNJg1LWWCMGQ6qTtKgPWMtZycFasFa7zeql2wgw4Pymur_gR8uFc6JNs5UNC3SPPW5DSgFHFdM8MRpqghrQYuM-vjwtpN7QCmy20E7Y6gxy-j3ah7v1dUMIrYXMz5IyD4n1Meohps7MA5PYKfosJcUioZoeQ_pEIiwmQ9U9__I936KYx5qCobh9GmzpPLKrSouuBjDNA_1Y2Rmv2mZkOp2VBq8VtOefd3v08JB4OR3zUm0kQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805462983</pqid></control><display><type>article</type><title>Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central (Open access)</source><creator>Seyhan, Ekrem Cengiz ; Gunluoglu, Gulşah ; Gunluoglu, Mehmet Zeki ; Tural, Seda ; Sökücü, Sinem</creator><creatorcontrib>Seyhan, Ekrem Cengiz ; Gunluoglu, Gulşah ; Gunluoglu, Mehmet Zeki ; Tural, Seda ; Sökücü, Sinem</creatorcontrib><description>Hemodialysis (HD) patients are at increased risk of reactivation of latent tuberculosis infection (LTBI) compared with the general population. QuantiFERON-TB Gold (QFT-G) for LTBI detection is more promising than tuberculin skin test (TST) in HD patients.
In our study, we evaluated the value of the TST and QFT-G In-Tube (QFG-IT) test in the development of active tuberculosis (TB), in the HD patients, and in healthy controls.
The study enrolled 95 HD patients and ninety age-matched, healthy controls. The TST and QFG-IT were performed. All the subjects were followed up 5 years for active TB disease.
Compared to the healthy controls, a high prevalence of LTBI was found in the HD patients by QFG-IT (41% vs. 25%). However, no significant difference was detected by TST (32% vs. 31%). Four HD patients and one healthy control progressed to active TB disease within the 5-year follow-up. For active TB discovered subjects, QFG-IT was positive in all, but TST was positive in two (one patient and one healthy control). In HD patients; sensitivity, specificity, positive and negative predictive values of QFG-IT, and TST for active TB was 100% and 25%, 62% and 67%, 10%, and 3%, and 100% and 95%, respectively. Receiver operating curve analysis revealed that the results are significantly different (P = 0.04).
QFG-IT test is a more useful diagnostic method than TST for detecting those who will progress to active TB in HD patients.</description><identifier>ISSN: 1817-1737</identifier><identifier>EISSN: 1998-3557</identifier><identifier>DOI: 10.4103/1817-1737.180023</identifier><identifier>PMID: 27168859</identifier><language>eng</language><publisher>India: Medknow Publications & Media Pvt. Ltd</publisher><subject>Active tuberculosis ; Antigens ; Diabetes ; Disease ; healthy controls ; Hemodialysis ; hemodialysis patients ; HIV ; Human immunodeficiency virus ; Infections ; Mortality ; Original ; Patients ; QuantiFERON-tuberculosis Gold In-Tube ; Studies ; tuberculin skin test ; Tuberculosis</subject><ispartof>Annals of thoracic medicine, 2016-04, Vol.11 (2), p.114-120</ispartof><rights>Copyright Medknow Publications & Media Pvt Ltd Apr-Jun 2016</rights><rights>Copyright: © 2016 Annals of Thoracic Medicine 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73</citedby><cites>FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854057/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1805462983?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27168859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seyhan, Ekrem Cengiz</creatorcontrib><creatorcontrib>Gunluoglu, Gulşah</creatorcontrib><creatorcontrib>Gunluoglu, Mehmet Zeki</creatorcontrib><creatorcontrib>Tural, Seda</creatorcontrib><creatorcontrib>Sökücü, Sinem</creatorcontrib><title>Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients</title><title>Annals of thoracic medicine</title><addtitle>Ann Thorac Med</addtitle><description>Hemodialysis (HD) patients are at increased risk of reactivation of latent tuberculosis infection (LTBI) compared with the general population. QuantiFERON-TB Gold (QFT-G) for LTBI detection is more promising than tuberculin skin test (TST) in HD patients.
In our study, we evaluated the value of the TST and QFT-G In-Tube (QFG-IT) test in the development of active tuberculosis (TB), in the HD patients, and in healthy controls.
The study enrolled 95 HD patients and ninety age-matched, healthy controls. The TST and QFG-IT were performed. All the subjects were followed up 5 years for active TB disease.
Compared to the healthy controls, a high prevalence of LTBI was found in the HD patients by QFG-IT (41% vs. 25%). However, no significant difference was detected by TST (32% vs. 31%). Four HD patients and one healthy control progressed to active TB disease within the 5-year follow-up. For active TB discovered subjects, QFG-IT was positive in all, but TST was positive in two (one patient and one healthy control). In HD patients; sensitivity, specificity, positive and negative predictive values of QFG-IT, and TST for active TB was 100% and 25%, 62% and 67%, 10%, and 3%, and 100% and 95%, respectively. Receiver operating curve analysis revealed that the results are significantly different (P = 0.04).
QFG-IT test is a more useful diagnostic method than TST for detecting those who will progress to active TB in HD patients.</description><subject>Active tuberculosis</subject><subject>Antigens</subject><subject>Diabetes</subject><subject>Disease</subject><subject>healthy controls</subject><subject>Hemodialysis</subject><subject>hemodialysis patients</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Infections</subject><subject>Mortality</subject><subject>Original</subject><subject>Patients</subject><subject>QuantiFERON-tuberculosis Gold In-Tube</subject><subject>Studies</subject><subject>tuberculin skin test</subject><subject>Tuberculosis</subject><issn>1817-1737</issn><issn>1998-3557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkk1v1DAQhiMEoqVw54QiceklxY7t2L4goaotK1UU0N4tJ550vTjxYjsr9bfwZ3FIt2I5cfHH-J3HM6O3KN5idEExIh-wwLzCnPALLBCqybPiFEspKsIYf57Ph-eT4lWMW4RYQwl_WZzUHDdCMHla_PoawNgu2T2Ue-0mKH1fpg2UaWohdJOzYxl_5CVBTKUeTflt0mOy11ff775UB5GPNpY33plyNVbrHFzkvQ-lgT04vxtgTDNaL18dJWb6BgZvrHYP832nk83y-Lp40WsX4c3jflasr6_Wl5-r27ub1eWn26pjNUkVEaKXCIsa91IQbnpSY2M4IxiZhjQIjGBaNJg1LWWCMGQ6qTtKgPWMtZycFasFa7zeql2wgw4Pymur_gR8uFc6JNs5UNC3SPPW5DSgFHFdM8MRpqghrQYuM-vjwtpN7QCmy20E7Y6gxy-j3ah7v1dUMIrYXMz5IyD4n1Meohps7MA5PYKfosJcUioZoeQ_pEIiwmQ9U9__I936KYx5qCobh9GmzpPLKrSouuBjDNA_1Y2Rmv2mZkOp2VBq8VtOefd3v08JB4OR3zUm0kQ</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Seyhan, Ekrem Cengiz</creator><creator>Gunluoglu, Gulşah</creator><creator>Gunluoglu, Mehmet Zeki</creator><creator>Tural, Seda</creator><creator>Sökücü, Sinem</creator><general>Medknow Publications & Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160401</creationdate><title>Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients</title><author>Seyhan, Ekrem Cengiz ; Gunluoglu, Gulşah ; Gunluoglu, Mehmet Zeki ; Tural, Seda ; Sökücü, Sinem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Active tuberculosis</topic><topic>Antigens</topic><topic>Diabetes</topic><topic>Disease</topic><topic>healthy controls</topic><topic>Hemodialysis</topic><topic>hemodialysis patients</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Infections</topic><topic>Mortality</topic><topic>Original</topic><topic>Patients</topic><topic>QuantiFERON-tuberculosis Gold In-Tube</topic><topic>Studies</topic><topic>tuberculin skin test</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seyhan, Ekrem Cengiz</creatorcontrib><creatorcontrib>Gunluoglu, Gulşah</creatorcontrib><creatorcontrib>Gunluoglu, Mehmet Zeki</creatorcontrib><creatorcontrib>Tural, Seda</creatorcontrib><creatorcontrib>Sökücü, Sinem</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of thoracic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seyhan, Ekrem Cengiz</au><au>Gunluoglu, Gulşah</au><au>Gunluoglu, Mehmet Zeki</au><au>Tural, Seda</au><au>Sökücü, Sinem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients</atitle><jtitle>Annals of thoracic medicine</jtitle><addtitle>Ann Thorac Med</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>11</volume><issue>2</issue><spage>114</spage><epage>120</epage><pages>114-120</pages><issn>1817-1737</issn><eissn>1998-3557</eissn><abstract>Hemodialysis (HD) patients are at increased risk of reactivation of latent tuberculosis infection (LTBI) compared with the general population. QuantiFERON-TB Gold (QFT-G) for LTBI detection is more promising than tuberculin skin test (TST) in HD patients.
In our study, we evaluated the value of the TST and QFT-G In-Tube (QFG-IT) test in the development of active tuberculosis (TB), in the HD patients, and in healthy controls.
The study enrolled 95 HD patients and ninety age-matched, healthy controls. The TST and QFG-IT were performed. All the subjects were followed up 5 years for active TB disease.
Compared to the healthy controls, a high prevalence of LTBI was found in the HD patients by QFG-IT (41% vs. 25%). However, no significant difference was detected by TST (32% vs. 31%). Four HD patients and one healthy control progressed to active TB disease within the 5-year follow-up. For active TB discovered subjects, QFG-IT was positive in all, but TST was positive in two (one patient and one healthy control). In HD patients; sensitivity, specificity, positive and negative predictive values of QFG-IT, and TST for active TB was 100% and 25%, 62% and 67%, 10%, and 3%, and 100% and 95%, respectively. Receiver operating curve analysis revealed that the results are significantly different (P = 0.04).
QFG-IT test is a more useful diagnostic method than TST for detecting those who will progress to active TB in HD patients.</abstract><cop>India</cop><pub>Medknow Publications & Media Pvt. Ltd</pub><pmid>27168859</pmid><doi>10.4103/1817-1737.180023</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1817-1737 |
ispartof | Annals of thoracic medicine, 2016-04, Vol.11 (2), p.114-120 |
issn | 1817-1737 1998-3557 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_efb0a7bd5b7e4407a25d7014063bae79 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central (Open access) |
subjects | Active tuberculosis Antigens Diabetes Disease healthy controls Hemodialysis hemodialysis patients HIV Human immunodeficiency virus Infections Mortality Original Patients QuantiFERON-tuberculosis Gold In-Tube Studies tuberculin skin test Tuberculosis |
title | Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20value%20of%20the%20tuberculin%20skin%20test%20and%20QuantiFERON-tuberculosis%20Gold%20In-Tube%20test%20for%20development%20of%20active%20tuberculosis%20in%20hemodialysis%20patients&rft.jtitle=Annals%20of%20thoracic%20medicine&rft.au=Seyhan,%20Ekrem%20Cengiz&rft.date=2016-04-01&rft.volume=11&rft.issue=2&rft.spage=114&rft.epage=120&rft.pages=114-120&rft.issn=1817-1737&rft.eissn=1998-3557&rft_id=info:doi/10.4103/1817-1737.180023&rft_dat=%3Cproquest_doaj_%3E1789035927%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-388f901821f9837df321dd75310d6360ed85a86156b458350dc9ac43e5f55b73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1805462983&rft_id=info:pmid/27168859&rfr_iscdi=true |